Vera Therapeutics Has a July 7 Deadline. The Market Is Barely Watching.
A kidney disease drug with Breakthrough Therapy status is 11 days from an FDA decision.
Category: Politics
NVIDIA Is About to Flip the Switch on Vera Rubin
The next chip generation is in full production. The market may be underpricing what comes next.
The Stress Test Results Are Out Today. Here Is What the Banks Actually Win.
This is not about capital ratios. It is about the dividend and buyback wave that comes next.
IBM Just Got a Double Catalyst. The July 22 Earnings Date Is Where It Gets Complicated.
Trump’s June 22 quantum executive orders and a JPMorgan upgrade fired IBM up about 5% on a day the Nasdaq fell 2.2%. The real question is what happens between now and July 22.
Kroger Dropped 8% on a One-Cent Miss. The Penny Wasn’t the Problem.
KR just hit a fresh 52-week low. What the market is actually pricing is more complicated than the headline suggests.
Semtech Is Up 117% This Year and Still Has a $204 Analyst Target — The 1.6T Optical Trade Explained
SMTC isn’t a household name. But the AI data center networking buildout is making it one of the market’s most watched semiconductor stories.
The Healthcare Sector Has Been Left for Dead. That’s the Setup Bargain Hunters Have Been Waiting For.
Three years of underperformance, a 20% valuation discount, and a mean-reversion case that’s getting harder to ignore.
Eli Lilly Just Became Something Bigger Than a Drug Company
Q1 blowout, raised guidance, oral GLP-1 coverage expansion — LLY is redefining what a pharmaceutical platform looks like.
Meta’s Next Billion-Dollar Bet Is Still Just a Hint
Q1 results were strong. The cloud business Zuckerberg dangled? Not happening yet — but the setup is interesting.
ServiceNow Just Got a Vote of Confidence From Wall Street – The AI Margin Story Is Only Getting Started
Analysts argue generative AI expands ServiceNow’s software margins rather than threatening them. The market is beginning to agree.